National Association of Testing Authorities, Australia
Scope of Accreditation
NSW Health Pathology
Site
NSW Health Pathology Wagga Wagga Hospital Laboratory
Accreditation No.
2154
Site No.
3024
Date of Accreditation
26 Nov 1990
Address
260-280 Edward Street
Wagga Wagga, NSW 2650
Australia
Contact
Mr Mostafa Lashin P: +61 0460031062
Availability
Services available to external clients
Supervision
GY (General)
Scope of Accreditation
NSW Health Pathology Wagga Wagga Hospital Laboratory
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
24 Nov 2027
Last Activity Date
29 Oct 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue; Fresh tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities; Structured reporting |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material; Rapid onsite evaluation (ROSE) |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma; Serum | Paracetamol (acetaminophen); Salicylate |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma; Serum | Carbamazepine; Digoxin; Ethanol; Gentamicin (cidomycin, septopal, genticyn, garamycin); Phenytoin (dilantin); Valproate (valproic acid, epilim); Vancomycin |
| Serum | Lithium | |
| Chemical pathology - Detection and/or quantitation of tumour markers | Serum | Prostate specific antigen (PSA) |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Serum | Cortisol |
| Follicle stimulating hormone (FSH); Luteinising hormone (LH); Oestradiol; Parathyroid hormone (PTH); Progesterone; Prolactin | ||
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Further investigation of cardiac function | Plasma | N-Terminal-pro b-type natriuretic peptide (NT-proBNP) |
| Plasma; Serum | Troponin I | |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | HDL - Quantitation |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Calcium - Ionised; Glucose; Potassium; Sodium |
| Cerebrospinal fluid (CSF) | Glucose; Protein - Total | |
| Drainage fluid | Creatinine | |
| Drainage fluid; Peritoneal fluid; Pleural fluid | Albumin; Cholesterol - Total; Glucose; Lactate dehydrogenase (LDH); Protein - Total; Triglycerides | |
| Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Ammonia; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
| Plasma; Serum; Urine | Osmolality | |
| Pleural fluid | Amylase; Bilirubin - Total; Lipase; Urate | |
| Urine | Albumin; Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Osmolality; Phosphate; Potassium; Protein - Total; Sodium; Urea; Uric acid | |
| Chemical pathology - Investigation for folate deficiency | Plasma; Serum | Folate |
| Chemical pathology - Iron studies | Plasma; Serum | Ferritin; Iron; Transferrin |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); pH |
| Chemical pathology - Quantitation of vitamins | Serum | Cobalamin (vitamin B12) |
| Chemical pathology - Tests for thyroid function | Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Haematology - Full blood examination | Blood | Differential number; Morphology |
| Morphology | ||
| Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocytes | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Plasma | Activated partial thromboplastin time (APTT); Anti-Xa activity - Low molecular weight heparin; D-dimer; Fibrinogen; Prothrombin time (PT); Thrombin time (TT) |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunohaematology - Blood group antibody detection | Blood; Plasma | Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood; Plasma | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody elution |
| Blood; Plasma | Other blood group antibodies; Red blood cell phenotyping; Rh | |
| Plasma | Antibody titration | |
| Immunohaematology - Investigation of blood transfusion reactions | Blood; Blood products | Antibodies; Contamination - Microbiological; Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Compliance with transport, storage and distribution requirements of blood, products and components; Issue and release of blood and blood products for transfusion |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Blood; Cerebrospinal fluid (CSF); Cervical swabs; Ear swabs; Eye swabs; Faeces; Nasal swabs; Sputum; Synovial fluid; Throat swabs; Urethra; Urine; Vaginal swabs; Wound swabs | Bacteria; Cultured pathogens identification; Pathogenic identification; Pathogenic microorganisms |
| Pathogenic identification and antibiotic susceptibility | ||
| Antibiotic susceptibility; Bacteria; Pathogenic identification and antibiotic susceptibility; Pathogenic microorganisms | ||
| Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
| Aspirates; Blood; Cerebrospinal fluid (CSF); Cervical swabs; Ear swabs; Eye swabs; Nasal swabs; Sputum; Synovial fluid; Throat swabs; Urethra; Urine; Vaginal swabs; Wound swabs | Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Bacteria; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Pathogenic microorganisms | ||
| Blood | Bacteria; Cultured pathogens identification; Pathogenic microorganisms | |
| Faeces | Clostridioides difficile toxin | |
| Isolates | Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus spp. | |
| Urine | Bacteria; Pathogenic microorganisms | |
| Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | ||
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Bacterial isolates; Blood transfusion bags; Bronchoscopes; Catheter tips; Dialysis waters; Endoscopes; Environmental swabs; Gastrointestinal endoscopes; Vascular catheter tips | Bacterial growth - Sterility |
| Environmental swabs; Gastrointestinal endoscopes; Vascular catheter tips | Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE) | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Blood culture; Fluids; Nasal swabs | Staphylococcus aureus; Staphylococcus spp.; MecA gene; MecC gene; Methicillin resistant Staphylococcus aureus (MRSA) |
| Faeces | Campylobacter coli; Campylobacter jejuni; Clostridioides difficile; Clostridium difficile toxin B; Escherichia coli - Enteroinvasive (EIEC); Salmonella spp.; Shigella spp.; Shiga toxin | |
| Vaginal swabs | Streptococcus agalactiae (Streptococcus group B) | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces | Cryptosporidium hominis; Cryptosporidium parvum; Entamoeba histolytica; Giardia lamblia |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Combined nose and throat swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Faeces | Adenovirus F40; Adenovirus F41; Astrovirus; Norovirus G1; Norovirus G2; Rotavirus A; Sapovirus | |
| Nasal swabs; Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Respiratory specimens | Mycobacteria identification |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF); Fluids; Respiratory swabs; Tissues; Urine; Wound swabs | Fungi identification; Yeasts identification |
| Fungi identification; Yeasts identification | ||
| Cerebrospinal fluid (CSF); Fluids; Respiratory swabs; Tissues; Wound swabs | Fungi identification; Yeasts identification | |
| Fungi identification; Yeasts identification | ||
| Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood | Infectious mononucleosis |
| Serum | Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus antibody (anti-HCV) - Total; Human immunodeficiency virus (HIV) p24 antigen; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Rubella IgG antibody |
Cardiac Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Nov 2027
Last Activity Date
29 Oct 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Emergency Department
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Nov 2027
Last Activity Date
29 Oct 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR); Prothrombin time (PT) |
Emergency Medical Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Nov 2027
Last Activity Date
29 Oct 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Nov 2027
Last Activity Date
29 Oct 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Maternity OPT
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Nov 2027
Last Activity Date
29 Oct 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Calcium - Ionised; Chloride; Creatinine; Potassium; Sodium; Total carbon dioxide (TCO2); Urea |
| Haematology - Full blood examination | Blood | Haematocrit (packed cell volume, PCV); Total haemoglobin - Calculated |
Operating Theatres
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Nov 2027
Last Activity Date
29 Oct 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); pH |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR); Prothrombin time (PT) |
Paediatrics
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Nov 2027
Last Activity Date
29 Oct 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Calcium - Ionised; Glucose; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Haematology - Full blood examination | Blood | Haematocrit (packed cell volume, PCV); Haemoglobin (Hb) |
Pathology Collection
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Nov 2027
Last Activity Date
29 Oct 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Special Care Nursery
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Nov 2027
Last Activity Date
29 Oct 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Glucose |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2154
Site No.
3024
Print date
10 Feb 2026
END OF SCOPE